XML 14 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:        
Net income $ 13,588 $ 10,708 $ 31,641 $ 5,592
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation, amortization and accretion expense 20,033 20,736 69,671 57,903
Amortization of deferred financing costs     1,453 1,452
Credit loss expense       81
Deferred income tax benefit     (2,918) (4,770)
Equity-based employee and director compensation expense     1,353 1,134
(Gain) loss on dispositions and lease terminations, net (7,387) (4,682) (40,789) 6,546
Changes in operating assets and liabilities, net of acquisitions     1,654 8,734
Net cash provided by operating activities     62,065 76,672
Cash flows from investing activities:        
Principal payments received on notes receivable     92 117
Proceeds from sale of assets     94,788 17,969
Capital expenditures     (28,657) (19,131)
Lease termination payments to Applegreen, including inventory purchases       (25,517)
Net cash provided by (used in) investing activities     66,223 (26,562)
Cash flows from financing activities:        
Borrowings under the Credit Facility     49,000 90,919
Repayments on the Credit Facility     (111,000) (74,500)
Payments of finance lease obligations     (2,430) (2,294)
Payments of deferred financing costs       (74)
Distributions paid on distribution equivalent rights     (218) (194)
Income tax distributions paid on preferred membership interests (1,300) (1,300) (1,261) (1,312)
Distributions paid on common units     (59,994) (59,880)
Net cash used in financing activities     (125,903) (47,335)
Net increase in cash and cash equivalents     2,385 2,775
Cash and cash equivalents at beginning of period     3,381 4,990
Cash and cash equivalents at end of period $ 5,766 $ 7,765 $ 5,766 $ 7,765